Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

5(100.0%)

5Total

N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06466148Not ApplicableTerminated

JessieHug Feasibility and Usability Assessment

Role: collaborator

NCT05301673Active Not Recruiting

ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence

Role: collaborator

NCT06275685Not ApplicableRecruiting

Forecasting Seizures Using Intelligent Wearable Technology for Health Tracking

Role: lead

NCT04964609Not ApplicableCompleted

EmbracePlus SpO2 Accuracy Validation

Role: lead

NCT04807608Completed

EmbracePlus, Care App and Aura Usability Study

Role: lead

NCT03207685Not ApplicableUnknown

Generalized Seizure Detection And Alerting In The EMU With The Empatica Embrace Watch And Smartphone-Based Alert System

Role: lead

NCT03206502Not ApplicableEnrolling By Invitation

Embrace: Seizure Characterization

Role: lead

All 7 trials loaded